Krebs Biochemicals & Industries reports standalone net loss of Rs 5.40 crore in the September 2026 quarter

Sales rise 38.85% to Rs 5.79 crore

Net Loss of Krebs Biochemicals & Industries reported to Rs 5.40 crore in the quarter ended September 2026 as against net loss of Rs 6.14 crore during the previous quarter ended September 2025. Sales rose 38.85% to Rs 5.79 crore in the quarter ended September 2026 as against Rs 4.17 crore during the previous quarter ended September 2025.

Particulars	Quarter Ended
	Sep. 2026	Sep. 2025	% Var.
Sales	5.79	4.17	39
OPM %	-33.33	-67.15	-
PBDT	-3.79	-4.52	16
PBT	-5.40	-6.14	12
NP	-5.40	-6.14	12

Powered by Capital Market - Live News